Let's focus on what we can do!

By Disabled People for Disabled People

  • Home
  • >
  • Ataxia
  • >
  • Agilis Biotherapeutics and Waisman Biomanufacturing Enter Into Exclusive Manufacturing Agreement for Friedreich’s … – Business Wire (press release)

Agilis Biotherapeutics and Waisman Biomanufacturing Enter Into Exclusive Manufacturing Agreement for Friedreich’s … – Business Wire (press release)

Friday, 19 February, 2016

Agilis Biotherapeutics and Waisman Biomanufacturing Enter Into Exclusive Manufacturing Agreement for Friedreich’s … – Business Wire (press release)

It is the most common inherited ataxia, with 1 in every 100 people being carriers of a mutated FXN gene. FA typically arises between the ages of 5 and 15 and manifests as difficulty with balance and coordination. Over time, the disease progresses to an ...

Read More

Source:Agilis Biotherapeutics and Waisman Biomanufacturing Enter Into Exclusive Manufacturing Agreement for Friedreich's ... - Business Wire (press release)

Categories :
  • Ataxia
  • Latest Headlines
  • Uncategorized
Socials :

Recent posts